Division of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
University of Chinese Academy of Sciences, Beijing, 100049, China.
Adv Healthc Mater. 2024 Aug;13(21):e2302686. doi: 10.1002/adhm.202302686. Epub 2023 Dec 28.
Organoids have emerged as major technological breakthroughs and novel organ models that have revolutionized biomedical research by recapitulating the key structural and functional complexities of their in vivo counterparts. The combination of organoid systems and microfluidic technologies has opened new frontiers in organoid engineering and offers great opportunities to address the current challenges of existing organoid systems and broaden their biomedical applications. In this review, the key features of the existing organoids, including their origins, development, design principles, and limitations, are described. Then the recent progress in integrating organoids into microfluidic systems is highlighted, involving microarrays for high-throughput organoid manipulation, microreactors for organoid hydrogel scaffold fabrication, and microfluidic chips for functional organoid culture. The opportunities in the nascent combination of organoids and microfluidics that lie ahead to accelerate research in organ development, disease studies, drug screening, and regenerative medicine are also discussed. Finally, the challenges and future perspectives in the development of advanced microfluidic platforms and modified technologies for building organoids with higher fidelity and standardization are envisioned.
类器官已成为重大技术突破和新型器官模型,通过重现体内对应物的关键结构和功能复杂性,彻底改变了生物医学研究。类器官系统与微流控技术的结合为类器官工程开辟了新的前沿领域,并为解决现有类器官系统的当前挑战和拓宽其生物医学应用提供了巨大机会。在这篇综述中,描述了现有类器官的关键特征,包括它们的起源、发展、设计原则和局限性。然后强调了将类器官集成到微流控系统中的最新进展,涉及用于高通量类器官操作的微阵列、用于类器官水凝胶支架制造的微反应器以及用于功能性类器官培养的微流控芯片。还讨论了类器官和微流控技术相结合所带来的新兴机遇,以加速器官发育、疾病研究、药物筛选和再生医学的研究。最后,设想了在开发高级微流控平台和改进技术以构建具有更高保真度和标准化的类器官方面面临的挑战和未来展望。